Abstract
Abstract No. 24 The PERIO-03 Trial: Technical Feasibility and Safety of a Novel Pancreatic Retrograde Venous Immunotherapy Infusion Intervention for Locally Advanced Pancreatic Ductal Adenocarcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have